{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:08:58Z","timestamp":1788307738539,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.vaccine.2012.02.057","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T04:34:52Z","timestamp":1331008492000},"page":"2824-2830","source":"Crossref","is-referenced-by-count":20,"title":["Health outcomes of interest for evaluation in the Post-Licensure Rapid Immunization Safety Monitoring Program"],"prefix":"10.1016","volume":"30","author":[{"given":"Tracy A.","family":"Lieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.02.057_bib0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.99.6.765","article-title":"Vaccine Safety Datalink Project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team","volume":"99","author":"Chen","year":"1997","journal-title":"Pediatrics"},{"issue":"May (Suppl. 1)","key":"10.1016\/j.vaccine.2012.02.057_bib0010","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"issue":"Jan (Suppl 1)","key":"10.1016\/j.vaccine.2012.02.057_bib0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/pds.2318","article-title":"Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future research","volume":"21","author":"Carnahan","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2012.02.057_bib0020","unstructured":"Salmon DA, Yih WK, Lee GM, Rosofsky R, Brown, Vannice K, et al. Development of national systems for monitoring the safety of medical products: lessons from a new Vaccine Safety Surveillance Program; Unpublished manuscript."},{"issue":"Jan Suppl 11)","key":"10.1016\/j.vaccine.2012.02.057_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.2323","article-title":"FDA's Post-Licensure Rapid Immunization Safety Monitoring Program: strengthening the federal vaccine safety enterprise","volume":"21","author":"Nguyen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2012.02.057_bib0030","series-title":"Adverse effects of vaccines: evidence and causality","author":"Institutes of Medicine (IOM)","year":"2011"},{"key":"10.1016\/j.vaccine.2012.02.057_bib0035","series-title":"The Brighton Collaboration: creating a global standard for case following","author":"Kohl","year":"2005"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2012.02.057_bib0040","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J Adv Nurs"},{"issue":"1","key":"10.1016\/j.vaccine.2012.02.057_bib0045","doi-asserted-by":"crossref","first-page":"e1000393","DOI":"10.1371\/journal.pmed.1000393","article-title":"Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies","volume":"8","author":"Sinha","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2012.02.057_bib0050","series-title":"FDA's sentinel initiative: transforming how we monitor the safety of FDA-regulated products","author":"USFDA","year":"2011"},{"issue":"June (9790)","key":"10.1016\/j.vaccine.2012.02.057_bib0055","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(11)60678-8","article-title":"Addressing the vaccine confidence gap","volume":"378","author":"Larson","year":"2011","journal-title":"Lancet"},{"issue":"July (9788)","key":"10.1016\/j.vaccine.2012.02.057_bib0060","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(11)60440-6","article-title":"Vaccine discovery and translation of new vaccine technology","volume":"378","author":"Rappuoli","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.02.057_bib0065","series-title":"Public workshop: adjuvants and adjuvanted preventative and therapeutic vaccines for infectious disease indications","author":"USFDA","year":"2008"},{"issue":"May (Suppl. 1)","key":"10.1016\/j.vaccine.2012.02.057_bib0070","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1542\/peds.2010-1722F","article-title":"Statistical, epidemiological, and risk-assessment approaches to evaluating safety of vaccines throughout the life cycle at the Food and Drug Administration","volume":"127","author":"Ball","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.02.057_bib0075","doi-asserted-by":"crossref","unstructured":"Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, et al. Risk of confirmed Guillain\u2013Barr\u00e9 Syndrome following monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009\u20132010. Am J Epidemiol; in press.","DOI":"10.1093\/aje\/kws195"},{"key":"10.1016\/j.vaccine.2012.02.057_bib0080","doi-asserted-by":"crossref","first-page":"d3908","DOI":"10.1136\/bmj.d3908","article-title":"Guillain\u2013Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe","volume":"343","author":"Dieleman","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.02.057_bib0085","series-title":"Therapeutic Goods Administration. Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination","author":"Australian Government, Department of Health and Ageing","year":"2010"},{"issue":"December (21)","key":"10.1016\/j.vaccine.2012.02.057_bib0090","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with smallpox vaccination in the United States, January\u2013October 2003","volume":"294","author":"Casey","year":"2005","journal-title":"JAMA"},{"issue":"March (Suppl. 3)","key":"10.1016\/j.vaccine.2012.02.057_bib0095","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1086\/524749","article-title":"Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board","volume":"46","author":"Neff","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2012.02.057_bib0100","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.02.057_bib0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200104000-00008","article-title":"Population-based study of rotavirus vaccination and intussusception","volume":"20","author":"Kramarz","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.02.057_bib0110","unstructured":"The Immunization Safety Office Scientific Agenda. Available from: http:\/\/www.cdc.gov\/vaccinesafety\/agenda.htm [accessed 25.08.11] [database on the Internet]."},{"key":"10.1016\/j.vaccine.2012.02.057_bib0115","unstructured":"National Vaccine Program Office. National Vaccine Advisory Committee (NVAC) recommendations on the Centers for Disease Control and Prevention Immunization Safety Office draft 5-Year scientific agenda. Available from http:\/\/www.hhs.gov\/nvpo\/nvac\/subgroups\/vaccinesafety.html#1 [accessed 25.08.11]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12002514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12002514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T03:58:33Z","timestamp":1713671913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12002514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":23,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0264410X12002514"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.02.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}